EAGLE, Idaho, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it has completed its purchase of the Washington and Idaho assets of Signature Healthcare at Home.
Pennant previously announced its agreement to purchase the Signature assets, with the planned closing of Signature’s Washington and Idaho assets on August 1, and a second purchase agreement capturing Signature’s Oregon business closing on January 1, 2025.
Today’s acquisition will add to Pennant’s existing strength in Idaho, and build out Pennant’s Washington footprint in a critical certificate of need state.
“Today is a significant milestone in Pennant’s investment in the Pacific Northwest,” said Brent Guerisoli, Pennant's Chief Executive Officer. “In Signature, we have a found a uniquely complementary opportunity in key communities and geographies for Pennant,” continued Mr. Guerisoli. “We are particularly excited about this acquisition in locations where Pennant has high-performing leaders and current operations who can support the Signature’s talented leaders and help them develop as they accelerate their ability to provide life changing service in their communities.”
"As we close on the first phase of this acquisition, and transition these Idaho and Washington operations, we are excited to welcome the Signature team to the Pennant family. We are grateful to the Signature team, all of whom have been so welcoming to our operational and service center teams as we have begun the work of transition,” said John Gochnour, Pennant’s President and Chief Operating Officer. “We look forward to building on Signature’s impressive legacy of quality care as we implement Pennant’s unique operating model, innovative technology stack, best practices, and world-class resource support to benefit communities across Washington and Western Idaho.”
About Pennant
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 117 home health and hospice agencies and 54 senior living communities located throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.
This press release was published by a CLEAR® Verified individual.
Last Trade: | US$27.38 |
Daily Change: | 0.08 0.29 |
Daily Volume: | 894,036 |
Market Cap: | US$940.500M |
December 17, 2024 November 06, 2024 November 01, 2024 September 30, 2024 August 06, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB